圣诺生物(688117.SH)发预增，预计前三季度归母净利润同比增加100.53%至145.10%

Core Viewpoint - Shengnuo Bio (688117.SH) expects a significant increase in net profit for the first three quarters of 2025, projecting a range of 114 million to 140 million yuan, representing a year-on-year increase of 57.25 million to 82.63 million yuan, or 100.53% to 145.10% [1] Group 1 - The company's main business is experiencing stable development, contributing to overall performance growth [1] - The demand for orders in the peptide raw material business is continuously increasing due to the ongoing capacity expansion [1] - The substantial growth in performance allows the company to maintain strong market competitiveness and sustained profitability [1]